An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors

P Wu, W Sun, H Zhang - Cancer Immunology, Immunotherapy, 2022 - Springer
Thyroid carcinoma (THCA) is the most common endocrine malignancy, and its incidence is
increasing worldwide. Several studies have explored whether the tumor immune …
被引用次数：9 相关文章

An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors

P Wu, W Sun, H Zhang - Cancer Immunology, Immunotherapy, 2022 - search.proquest.com
Thyroid carcinoma (THCA) is the most common endocrine malignancy, and its incidence is
increasing worldwide. Several studies have explored whether the tumor immune …

An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors.

P Wu, W Sun, H Zhang - Cancer Immunology, Immunotherapy: CII, 2021 - europepmc.org
Thyroid carcinoma (THCA) is the most common endocrine malignancy, and its incidence is
increasing worldwide. Several studies have explored whether the tumor immune …

An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors

P Wu, W Sun, H Zhang - … immunology, immunotherapy: CII, 2022 - pubmed.ncbi.nlm.nih.gov
Thyroid carcinoma (THCA) is the most common endocrine malignancy, and its incidence is
increasing worldwide. Several studies have explored whether the tumor immune …

An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors.

P Wu, W Sun, H Zhang - Cancer Immunology …, 2022 - search.ebscohost.com
Thyroid carcinoma (THCA) is the most common endocrine malignancy, and its incidence is
increasing worldwide. Several studies have explored whether the tumor immune …
[HTML] nih.gov

[HTML][HTML] An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors

P Wu, W Sun, H Zhang - Cancer Immunology, Immunotherapy: CII, 2022 - ncbi.nlm.nih.gov
Thyroid carcinoma (THCA) is the most common endocrine malignancy, and its incidence is
increasing worldwide. Several studies have explored whether the tumor immune …

An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors.

P Wu, W Sun, H Zhang - Cancer Immunology, Immunotherapy: CII, 2021 - europepmc.org
Thyroid carcinoma (THCA) is the most common endocrine malignancy, and its incidence is
increasing worldwide. Several studies have explored whether the tumor immune …